The post infection consequences of COVID-19 are only starting to be fully realized. Initially, studies indicated that patients with diabetes had a higher chance of serious complications from COVID-19. However, recent reports now suggest an increased risk of diabetes diagnosis after a COVID-19 infection. During this discussion of diabetes in the context of COVID-19, Dr. Kaufman will explain why hemoglobin A1c testing is even more important in today’s healthcare landscape, and will explore the hypotheses and pathophysiology behind this recent trend.
Key learning objectives
- Understand the pathophysiology of diabetes
- Learn how an infection or inflammation interacts with patients with diabetes
- Discover how COVID-19 altered diabetes assessment and management
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this one-hour webinar are also entitled to 1.0 ACCENT Continuing Education Credits from the AACC. This activity was planned in accordance with ACCENT® Standards and Policies. Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email firstname.lastname@example.org.